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The mechanism of circadian oscillations in mammals is cell autonomous and is generated by a set of genes that form a
transcriptional autoregulatory feedback loop. While these ‘‘clock genes’’ are well conserved among animals, their
specific functions remain to be fully understood and their roles in central versus peripheral circadian oscillators remain
to be defined. We utilized the in vivo inducible tetracycline-controlled transactivator (tTA) system to regulate Clock
gene expression conditionally in a tissue-specific and temporally controlled manner. Through the use of Secretogranin
II to drive tTA expression, suprachiasmatic nucleus– and brain-directed expression of a tetO::Clock
D19 dominant-
negative transgene lengthened the period of circadian locomotor rhythms in mice, whereas overexpression of a
tetO::Clock
wt wild-type transgene shortened the period. Low doses (10 lg/ml) of doxycycline (Dox) in the drinking
water efficiently inactivated the tTA protein to silence the tetO transgenes and caused the circadian periodicity to
return to a wild-type state. Importantly, low, but not high, doses of Dox were completely reversible and led to a rapid
reactivation of the tetO transgenes. The rapid time course of tTA-regulated transgene expression demonstrates that
the CLOCK protein is an excellent indicator for the kinetics of Dox-dependent induction/repression in the brain.
Interestingly, the daily readout of circadian period in this system provides a real-time readout of the tTA
transactivation state in vivo. In summary, the tTA system can manipulate circadian clock gene expression in a tissue-
specific, conditional, and reversible manner in the central nervous system. The specific methods developed here
should have general applicability for the study of brain and behavior in the mouse.
Citation: Hong HK, Chong JL, Song W, Song EJ, Jyawook AA, et al. (2007) Inducible and reversible Clock gene expression in brain using the tTA system for the study of
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Introduction
Most organisms possess an endogenous circadian system
that drives the daily timing of many physiological and
behavioral processes. Genetic screens, spontaneous mutants,
and gene-targeting approaches have been key in unraveling
the essential set of genes underlying the circadian mechanism
in mammals, Drosophila, and other model systems [1–4]. At the
molecular and biochemical levels, a set of core clock genes
govern positive and negative autoregulatory feedback loops
of transcription and translation to form the core mechanism
of the circadian clock in mammals [2,5]. The central oscillator
is primarily driven by two bHLH-PAS transcription factors
within the positive feedback loop, CLOCK and BMAL1, which
heterodimerize and transactivate downstream clock and
clock-controlled genes by binding to E-box elements that lie
within their promoters [6–9]. The core constituents of the
negative feedback loop are the Cry and Per genes, which are
transcriptionally driven by CLOCK and BMAL1. PER and
CRY proteins accumulate, associate with each other in the
cytoplasm, translocate to the nucleus, and inhibit the CLOCK
and BMAL1 activation of their own transcription [9]. As the
negative elements turn over, CLOCK and BMAL1 renew their
cycle of transcription of the Per and Cry genes.
In mammals, nearly all cells in the body contain circadian
oscillators organized in a hierarchical fashion, with a master
pacemaker located in the suprachiasmatic nucleus (SCN) of
the anterior hypothalamus [5,10,11]. The SCN is entrained to
the 24-h daily light–dark cycle via retinal light input and, in
turn, synchronizes and coordinates the rhythms of peripheral
tissue clock cells [2,5]. In mammals, luciferase reporters of
circadian genes [10,11] in conjunction with single cell imaging
have been valuable in revealing self-sustained circadian
oscillators in virtually every cell in the body [12–15]. These
studies have shown that most peripheral organs and tissues
can express circadian rhythms in isolation; however, inputs
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essential in coordinating circadian rhythms in an intact
animal [10,11,16,17]. For example, SCN transplant experi-
ments have shown that SCN-lesioned arrhythmic animals and
genetically arrhythmic mice take on the rhythm of the donor
SCN [17–19]. Similarly, transplanted mouse embryonic
ﬁbroblasts exhibit a circadian period and phase characteristic
of the host rhythm and phase [20]. These ﬁndings have led to
a widely accepted hierarchical model of the mammalian
circadian system in which the SCN acts as pacemaker that
drives and synchronizes peripheral circadian oscillators.
Thus, understanding the physiological and functional rela-
tionships among central and peripheral clocks is essential;
however, we still do not fully understand how the SCN
governs peripheral oscillators to regulate circadian rhythms
in physiology and behavior in multicellular organisms.
In nonmammalian systems, such as in Drosophila, analyses of
the regulatory interactions of circadian genes led to the
exploitation of novel tools to drive circadian genes, such as
tissue-speciﬁc expression of transgenes (TGs) and reporters,
which are valuable in elucidating the complexity of circadian
system [21–23]. Conditional systems utilizing heat shock
promoters have been developed in order to drive the
temperature-dependent expression of circadian TGs [24–
26]. Exogenous promoters in conjunction with the GAL4-
UAS bipartite transgenic system have been valuable in
expressing circadian TGs in subregions of the brain or
distinct groups of circadian neurons, and even in ablation of
discrete circadian neurons [27–30]. In mammals, however,
other than ubiquitous inactivation of circadian genes by gene
targeting techniques in embryonic stem cells or studies using
the culture/explant-based system, the use of tissue-speciﬁc
conditional regulation of circadian genes has not been
reported [2,3]. Thus, to elucidate cellular and behavioral
networks in the mammalian circadian system, more reﬁned
approaches are required, especially those affording temporal
and spatial control of gene expression in vivo.
The ability to regulate TG expression in a conditional
manner has made the tetracycline-controlled transactivator
(tTA) system an attractive tool for use in mammalian systems.
The tTA system was originally developed by Bujard and
colleagues for the conditional expression of reporter genes in
mammalian cells [31–34] and has been successfully applied in
many experiments to study a variety of developmental
processes and brain function in mammals [35–45]. The ﬁrst
component of this system contains a tissue-speciﬁc promoter
that drives the expression of tTA, a fusion of the Escherichia
coli tetracycline repressor sequence to the C-terminal trans-
activation domain of the herpes simplex virus VP16 gene that
converts the repressor into a transcriptional activator.
Expression of the target TG by tTA is achieved by introducing
the TG of interest downstream of a minimal cytomegalovirus
promoter sequence linked to multiple copies of the tet
operator (tetO) sequence. Conditional and inducible regu-
lation of the target TG is contingent on the ability of tTA to
bind to the tetO sequences and activate transcription in a
tetracycline-dependent manner. TG expression can be
turned off with the administration of doxycycline (Dox), a
tetracycline derivative, which prevents binding of tTA to the
tetO sequence. Thus, unlike the site-speciﬁc recombinase
Cre-loxP and Flp-FRT systems [46,47], which only allow
conditional and/or tissue-speciﬁc inactivation of genes [48],
the tTA system permits repeated cycles of conditional
activation and inactivation of genes within the same animal.
Hence, the tTA system provides truly conditional investigation
of gene function. Despite the widespread use of the Tet
system to manipulate various genes in a variety of tissues in
mammals, only a few studies have used the system in the
brain, and even fewer have used the system to study
regulation of behavior [35,37–39,41–43,45,49]. A limitation
of the tTA system in the study of brain function in vivo has
been the slow induction of the TG (i.e., reversal) upon
removal of standard dose of Dox [49].
Here we show that regulation of Clock
D19 or Clock
wt TG
expression occurs with rapid kinetics of induction and
repression, causing an immediate reversion of the mutant
to wild-type (WT) phenotype, and vice versa, in a tissue-
speciﬁc manner. We demonstrate that the CLOCK protein is
an excellent indicator for the kinetics of Dox-dependent
induction/repression in the brain. Using activity rhythms as
an output, the circadian period length provides a daily
readout of the transactivation state of the Tet system in vivo.
The development of the tTA system for conditional TG
expression in the brain/SCN will open new avenues of
research to answer fundamental questions of mammalian
circadian biology.
Results
Generation of Transactivator and Target Transgenic Lines
The tTA (also known as Tet-Off) system requires two
independent lines of transgenic mice (Figure 1A): one line
expresses tTA under the control of a speciﬁc promoter, and a
second line carries a tTA-responsive tetO promoter linked to
the target gene of interest [31–34]. When two TGs are
introduced into a single mouse through mating, the tetO-
linked gene is activated but only in those cells that express
tTA. Expression of the target TG can be suppressed by Dox.
To generate an SCN/brain-enriched transactivator line, we
ﬁrst searched for SCN-enriched transcripts that have ex-
PLoS Genetics | www.plosgenetics.org February 2007 | Volume 3 | Issue 2 | e33 0325
Tet-Regulated Clock Gene Expression in Brain
Author Summary
Although significant progress has been made in unraveling the
molecular mechanism of circadian clocks in mammals, previous
work has focused on germline mutations and in vitro methods for
analysis. To address the function of clock genes, it is necessary to
develop tools to manipulate circadian genes in a conditional and
tissue-specific manner in vivo. We report such an approach using
the tetracycline transactivator system. Despite the development of
the ‘‘tet’’ system in transgenic mice over 10 y ago by Bujard and
colleagues, there are still relatively few examples of the successful
use of the tet system in the central nervous system. Transgenic
expression of the Clock gene in the suprachiasmatic nucleus and
brain of mice regulated the period length of circadian locomotor
rhythms. These effects could be inhibited by low doses of
doxycycline in the drinking water. Importantly, low, but not high,
doses of doxycycline were completely reversible and led to a rapid
reactivation of the Clock transgenes. In summary, the tetracycline-
controlled transactivator system can manipulate circadian clock
gene expression in a tissue-specific, conditional, and reversible
manner in the central nervous system. The specific methods
developed here should have general applicability for the study of
brain and behavior in the mouse.pression restricted to the brain from the comprehensive
mouse tissue expression databases [50,51]. This analysis
revealed about 35 candidate genes that were either very
highly expressed in the SCN or SCN/brain enriched. We then
analyzed these candidate genes for SCN expression using in
situ hybridization. From this screen, we found one gene,
Secretogranin II (Scg2), that has very high constitutive expres-
sion in the SCN and has an expression pattern limited to
brain, pituitary, and adrenal glands [52]. Scg2 is a member of
the neuroendocrine/neuronal secretory proteins, which are
widely distributed in endocrine, neuroendocrine, and neuro-
nal cells [53,54]. Although the exact role of Scg2 is not well
understood, research suggests that Scg2 plays biologic roles in
neurotransmission and paracrine regulation of central and
Figure 1. Regulation of the Clock
D19 TG Using the tTA System
(A) Schematic diagram showing the Tet-Off system and constructs used for generating the tTA transactivator and target tetO transgenic lines. The Scg2
promoter drives the expression of tTA, which binds to an array of cognate operator sequences in the absence of Dox but not in its presence, resulting in
transcriptional activation or repression of the HA-tagged Clock
D19 TG, respectively.
(B) Analysis of the Scg2::tTA line: (a) in situ hybridization of the tTA transcript, using an antisense tTA oligo probe, on coronal brain slices; (b) in situ
hybridization of a control sense tTA oligo probe shows absence of specific hybridization and indicates that the antisense tTA oligo probe hybridization
is specific; and (c and d) b-galactosidase staining of SCN/brain-specific induction of the LacZ TG in Scg2::tTA/tetO-lacZ mice, using two different tetO-
lacZ reporter lines (lac1 and lac2).
(C) In situ hybridization of endogenous WT Clock and HA-tagged Clock
D19 TG from Scg2::tTA3tetO::Clock
D19-HA matings: representative coronal brain
slices of (a and b) WT mice; (c and d) single transgenic Scg2::tTA mice; (e and f) single transgenic tetO::Clock
D19-HA mice; and (g and h) double transgenic
Scg2::tTA/tetO::Clock
D19-HA mice.
(D) Western blot analysis of transgenically induced CLOCK
D19 and endogenous WT CLOCK in cerebellar lysates from all four possible genotypes. For the
double transgenic mice, total brain lysates from five of the independent lines are shown with their line identity numbers indicated. Two independent
mice from line 5 are also shown. The red asterisk indicates the WT protein, while the green asterisk denotes the HA-tagged CLOCK
D19.
(E) Western blot analysis of HA-tagged CLOCK
D19 of various tissues from the double transgenic mice.
(F–L) Immunocytochemical analysis of Scg2::tTA/tetO::Clock
D19-HA mice. (F) Nuclear location of the CLOCK
D19-HA. SCN/coronal sections were labeled
with anti-HA antibody to detect transgenically induced CLOCK
D19-HA (3100 magnification). (G–I) SCN/coronal sections were double labeled to detect
transgenically induced CLOCK
D19-HA (green, G) and endogenous vasopressin (AVP) (red, H). (I) Overlay of CLOCK
D19-HA and AVP expression. (J–L)
Double labeling of transgenically induced CLOCK
D19-HA (green, J) and endogenous VIP (red, K). (L) Overlay of CLOCK
D19-HA and VIP expression. Cells
that express both the CLOCK
D19-HA and VP/VIP are shown in yellow in overlaid figures. (G–L) Captured with a 320 objective.
doi:10.1371/journal.pgen.0030033.g001
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systems [54,55]. Because of its brain-enriched pattern of
expression and, in particular, its strong expression in the
SCN, we explored Scg2 as a tissue-speciﬁc activator for the
tTA system. We generated an SCN/brain-enriched trans-
activator line using a 9.8-kb promoter region of Scg2. We
examined the pattern of expression using an oligo probe
speciﬁc to the tTA transcript and showed distinct and strong
tTA expression in the SCN but also throughout the brain
(Figure 1Ba and 1Bb). To characterize tTA expression further,
we crossed the Scg2::tTA line to mice carrying a tetO
promoter-lacZ reporter construct [35]. We tested two in-
dependent tetO promoter-lacZ reporter lines, namely lines
lac1 and lac2 (kindly provided by Mark Mayford, Scripps
Research Institute, San Diego, California, United States). Both
reporter lines showed similar SCN/brain-enriched expression
patterns as demonstrated by b-galactosidase staining (Figure
1Bc and 1Bd). We used the Scg2::tTA line for all subsequent
experiments described in this report.
Next, we generated the target line, which carries a tetO
promoter fused to a dominant-negative Clock
D19 mutant allele
[56,57]. In order to clearly assess the inducible expression of
the TG, we also fused a hemagglutin (HA) epitope tag on the
39 end of the cDNA, which does not interfere with CLOCK
transcriptional activation [58]. We produced eight independ-
ent tetO::Clock
D19-HA transgenic lines, and all lines were
crossed to Scg2::tTA mice to evaluate whether we could
control the expression of the TG in a temporal manner.
Restricted Expression of the tetO-Linked Clock
D19 TG
We assessed whether the Clock
D19-HA TG is expressed in
Scg2::tTA/tetO::Clock
D19-HA double transgenic mice by in situ
hybridization using oligo probes targeted to exon 19 of the
Clock gene and to the HA tag (Figure 1C). The original ENU-
induced Clock
D19 mutation is an A-to-T transversion in a splice
donor site, causing skipping of exon 19 [57]; thus, the exon 19-
speciﬁc probe detects only the endogenous WT Clock tran-
script. Conversely, the HA tag-speciﬁc probe detects only the
Clock
D19-HA TG transcript. All mice showed endogenous WT
Clock transcript expression as expected. However, while only
double transgenic Scg2::tTA/tetO::Clock
D19-HA mice showed
clear hybridization with the HA tag-speciﬁc probe, single
transgenic (Scg2::tTA or tetO::Clock
D19-HA) and WT mice did
not show any expression of the HA tag. Thus, expression of
the Clock
D19-HA TG, which is evident in the SCN and
throughout the brain, is induced by tTA in the double
transgenic mice only. Similarly, Western blot analyses showed
that only the double transgenic mice expressed the mutant
TG protein (Figures 1D and S1A). Anti-CLOCK antibody
detects both the mutant and WT proteins, which can be
discriminated by their size difference. The lack of exon 19 in
the mutant allele results in the deletion of 51 amino acids and
subsequently produces a shorter protein for the Clock
D19-HA
TG compared to the WT allele. All eight independent
tetO::Clock
D19-HA transgenic lines expressed the mutant
protein when crossed to Scg2::tTA mice (Figures 1D and
S1A). In addition, the mean density ratio measurement of the
WT and mutant proteins in Western blot analyses revealed
that expression of the mutant protein is 0.51- to 1.05-fold
relative to the WT protein in these lines. This was also
demonstrated by Southern analysis (unpublished data), which
showed that target lines carried approximately one or two
copies of the TG. In order to test for leakiness of the tetO
promoter, we inspected whether the tetO::Clock
D19-HA single
transgenic mice from each independent line expressed the TG
using the anti-HA antibody against the brain lysates (Figure
S1B). Of the eight independent target lines, only one (line 12)
showed activation of the TG (likely due to a position effect on
the TG), and therefore this line was excluded from further
analysis. Thus, we obtained seven independent tetO target
lines that showed tightly regulated inducible expression.
We next assessed tissue speciﬁcity and spatial expression of
the Clock
D19-HA TG in double transgenic mice. Western blot
analyses indicated that expression of the TG is brain and SCN
enriched (Figure 1E). Because Scg2 participates in the neuro-
endocrine system [54,55], as expected, the TG was also
expressed in the pituitary gland (Figure 1E); however, there
was no expression in other peripheral tissues, such as the
kidney, lung, liver, and spleen. Using ﬂuorescence microscopy
and an HA tag antibody, we explored the spatial expression
of the TG within the SCN and found that Clock
D19-HA TG
expression is nuclear (Figure 1F). In WT mice, CLOCK has
been shown to be nuclear and is expressed constitutively in
the mouse SCN [59]. In contrast, rhythmically expressed
negative factors of the circadian gene, such as PER1, PER2,
and CRY1, accumulate in the nuclei at the end of circadian
night [59,60]. To delineate further the spatial organization of
the HA-containing cells within the SCN, we compared HA
expression with the distribution of neuropeptide markers
(Figure 1G–1L). Classically, the SCN is organized into two
major subdivisions: a core that lies adjacent to the optic
chiasm and is composed of neurons that predominantly
produce vasoactive intestinal polypeptide (VIP) and a shell
that surrounds the core and contain a large population of
neurons that produce arginine vasopressin (AVP) [61–64].
Examination of the HA-containing cells showed that more
than 90% of the cells in the SCN express the TG and that
expression occurs throughout both the core and the shell.
Serial sections through the rostral-caudal extent of the SCN
showed that HA-expressing cells colocalized with AVP- and
VIP-expressing cells (Figures 1F–1L, S2, and S3). Indeed, all
AVP- and VIP-positive cell bodies in the SCN were also HA
positive. Taken together, the detailed evaluation using West-
ern blot and immunocytochemical analyses demonstrates
that Scg2-driven Clock
D19-HA TG expression is tissue speciﬁc
and enriched in the brain and in the majority of cells in the
SCN, including the core and the shell.
Regulation of Conditionally Expressed Clock
D19 Allele by
Doxycycline: Changes in Behavioral Circadian Rhythms
The original N-ethyl-N-nitrosourea (ENU)-induced Clock
D19
mutant mice exhibit several behavioral alterations compared
to WT mice, one of which is the lengthened free-running
period of wheel-running activity. Heterozygous Clock
D19/þ
m i c es h o wal e n g t h e n i n go ft h ec i r c a d i a np e r i o do f
approximately 1 h, while homozygous Clock
D19/Clock
D19 mice
exhibit periods about 4 h longer compared to WT mice and
fail to express persistent circadian rhythms when maintained
in constant darkness [65]. Because the Clock
D19 mutant allele
behaves as an antimorph (one type of dominant-negative
mutation), it competes with the WT allele in the generation of
circadian rhythms [56,57,66]. In this study, because the
Scg2::tTA/tetO::Clock
D19-HA double transgenic mice express
the Clock
D19-HA TG as well as both copies of the endogenous
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free-running period of wheel activity rhythm similar to that
of the heterozygous Clock
D19/þ mice. To test this prediction,
running-wheel behavior of all four genotypes from the
Scg2::tTA x tetO::Clock
D19-HA matings was recorded (Figure
2). All mice entrained to a 12/12-h light–dark cycle, initiating
their nightly bouts of activity at the beginning of the dark
phase with the majority of locomotor activity restricted to the
night. Upon release into constant darkness (DD), however,
only the double transgenic mice displayed a lengthened
circadian period approximately 1 h greater than that of WT
mice (23.9 to 24.8 h versus 23.4 to 23.7 h, respectively).
Pairwise comparisons indicated that there were no signiﬁcant
differences in circadian period among the single transgenic
lines (Scg2::tTA or tetO::Clock
D19-HA) compared to WT
littermates, while the period observed in double transgenic
mice was signiﬁcantly longer compared to the WT, Scg2::tTA,
and tetO::Clock
D19-HA mice (mean DD comparison among all
genotypes, F3,78 ¼ 118.77, p , 0.00005; each pairwise
comparison [double transgenic versus others], p , 0.0005).
Double transgenic mice from all seven independent tetO
lines showed lengthening of the circadian period similar to
the circadian period exhibited in the heterozygous Clock
mutant mice. Therefore, conditional expression of the
dominant-negative mutant allele TG in the SCN and brain
is sufﬁcient to drive altered running wheel activity behavior.
As described above, these independent lines bear one or two
copies of the TG, and each line displays slightly different
Figure 2. Locomotor Activity Records of Progeny from Scg2::tTA x tetO::Clock
D19-HA Matings: Representative Actograms
Actograms are of (A) WT, (B) single transgenic Scg2::tTA, (C) single transgenic tetO::Clock
D19-HA, and (D) double transgenic Scg2::tTA/tetO::Clock
D19-HA
mice. Activity records were double plotted so that 48 h is represented horizontally, with each day presented beneath and to the right of the preceding
day. Wheel-running activity is indicated by black markings. The initial light cycle is depicted at the top of the record. All animals were maintained ona
12/12-h light–dark cycle for the first 12 to 14 d shown and then transferred to DD, as indicated by the bar next to each record. Numbers on the left
indicate days of study. Six of the seven independent lines are shown. All double transgenic mice showed a lengthening of free-running period of about
1 h. Mice that carry a single TG only (Scg2::tTA or tetO::Clock
D19-HA) showed a free-running period similar to WT littermates. At the indicated red circle,
all animals were given Dox (2 mg/ml) to ‘‘turn off’’ transgenically induced Clock
D19-HA TG. Only the double transgenic mice showed a shortening of
free-running period, indicating suppression of the Clock
D19-HA TG expression. Period estimates during the Dox treatment showed wheel activity rhythm
similar to WT mice. Administration of Dox in the single transgenic and WT mice showed no significant effects on the free-running period. Missing
activity data (blank lines) on several concurrent days was due to computer malfunction.
doi:10.1371/journal.pgen.0030033.g002
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Tet-Regulated Clock Gene Expression in Brainexpression levels (0.51- to 1.05-fold; Figure 1D). It is note-
worthy that those double transgenic mice, which carry one or
two copies of the Clock
D19 TG and two endogenous WT copies
of Clock, display a free-running period similar to that of the
Clock heterozygote mice (Clock
D19/þ), which carry one copy of
each allele (mutant and WT Clock). (There was a trend toward
longer circadian period in lines that expressed higher levels;
however, the differences were subtle.) It is not surprising,
therefore, that we do not observe a circadian rhythm
phenotype similar to that of Clock homozygous-like behavior
(i.e., 4-h lengthening and arrhythmicity) in double transgenic
mice, given the relative magnitude of TG expression in
relation to the expression of WT CLOCK.
One advantage of tetracycline controlled gene expression
is that a gene of interest can be repeatedly turned on and off
noninvasively. To examine Dox-dependent transactivation,
we treated all mice initially with 2 mg/ml Dox in their
drinking water (Figure 2). Upon treatment, the Scg2::tTA/
tetO::Clock
D19-HA double transgenic mice showed a short-
ening of circadian period in about a day, indicating a rapid
suppression of Clock
D19-HA TG expression. Period estimates
during the Dox treatment showed a mean circadian period of
23.7 h (SD ¼ 0.196, n ¼ 16) in double transgenic mice, similar
to their WT littermates (23.6 h, SD ¼ 0.108, n ¼ 22). Next, we
examined whether the effect was reversible by removing Dox
from the drinking water after 3 wk of treatment. The
circadian period of double transgenic mice, however, did
not immediately return to the previous long circadian period;
rather, it took longer than 3 mo for reversal (Figure 3). One
possibility for this long and gradual reversal of the circadian
period may be due to period ‘‘after effects’’, a form of
behavioral plasticity in which the free-running period of
circadian behavior undergoes experience-dependent
changes, such as, in this case, exposure to Dox [67,68].
However, Dox is a potent effector substance for the
tetracycline-controlled gene expression system and it is also
lipophilic in nature; thus, a likely possibility is that the dosage
used may have been too high to achieve rapid clearance and
subsequent rapid reversal. Earlier studies have shown that 2
mg/ml Dox produces a rapid switch-off of TG expression
(within 1 d) in many tissues and organs [69–71]; however, after
1 mo of treatment, clearance of the antibiotic can take as long
as 6 wk [71]. Consequently, we tested lower Dox concen-
trations in the range of 10 ng/ml to 100 lg/ml and found that
10 lg/ml Dox was optimal. Similar to 2 mg/ml Dox treatment,
the Clock
D19-HA TG was rapidly turned off at 10 lg/ml (Figure
4); double transgenic mice showed a shortening of their
circadian period of about 1 h, while single transgenic or WT
mice showed no effect of Dox treatment. No difference in
circadian period was observed among the genotypes with 10
lg/ml Dox treatment (F3,62 ¼ 1.93, p ¼ 0.1339). More
important, rapid reversal (switching-on) was achieved when
the double transgenic mice were returned to water; their
period lengthened by approximately 1 h within one or two
cycles (paired t-test, t22¼ 17.2177, p , 0.00005). In addition,
in situ hybridization revealed that Clock
D19-HA transcript in
the SCN and throughout the brain is sensitive to the presence
of 10 lg/ml Dox. By day 3 of treatment, the transcript is not
detectable. Therefore, a dose of 10 lg/ml Dox in the drinking
water can easily cross the blood-brain barrier and is sufﬁcient
Figure 3. Persistent Effects of 2 mg/ml Dox Treatment on Circadian Activity Rhythms of Scg2::tTA/tetO::Clock
D19-HA Double Transgenic Mice
Although the effect of Dox treatment was relatively rapid (þDox, also see Figure 2), the treatment was not immediately reversible upon returning to
water ( Dox) from 2 mg/ml Dox. It took at least 3 mo before the double transgenic mice returned to their original longer circadian period.
doi:10.1371/journal.pgen.0030033.g003
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In addition, we found that 100 lg/ml tetracycline in the
drinking water also worked effectively (Figure S4). The
magnitude and ease by which we can alter circadian wheel
running behavior using a low-dose provide ﬂexibility of
repeated activation and repression. Importantly, our data
argue that the circadian period is regulated through the
dynamic and daily expression of Clock and Clock-controlled
genes rather than through a static process established during
embryonic development.
Regulation of Conditionally Expressed Clock
D19 Allele by
Doxycycline: Changes in Behavioral Response to Discrete
Pulses of Light
Light remains one of the most well-understood circadian
entraining signals and perturbation analyses with light has
been exploited to demonstrate functional properties of the
circadian clock [72]. The phase-response curve (PRC) can be
considered a fundamental pacemaker property [67]. Expo-
sure to light early in the night phase shifts the clock so that
subsequent cycles begin at a later time; however, exposure to
light late in the night advances the circadian clock. These
time-dependent responses to light are important for syn-
chronization to environmental light conditions. Another
altered behavioral phenotype in Clock
D19/þ mice is high-
amplitude phase-resetting responses to a 6-h light pulse (type
0 resetting) compared to WT mice, which exhibit low-
amplitude (type 1) phase resetting [73]. In the C57BL/6J
inbred strain of mice, a 6-h light pulse near the ‘‘break-point’’
(the transition from phase delays to phase advances at
approximately circadian time [CT] 17) produces large phase
shifts of about 4 to 6 h; however, Clock heterozygotes display
phase shifts of longer than 6 h [73]. In order to assess whether
the conditional induction of Clock
D19-HA TG, restricted to
brain/SCN, recapitulates behavioral properties of Clock
D19/þ
heterozygous mice, we chose to characterize the phase
shifting response. Within the same animal, when Clock
D19-
HA TG is expressed (or when the mice are on water), their
phase shift is signiﬁcantly larger than when the TG is turned
off (when they are on Dox treatment) (Figure 5A). The
amplitude of phase shift in Scg2::tTA/tetO::Clock
D19-HA
double transgenic mice on Dox treatment is comparable to
the phase shift/delay described in WT mice after a 6-h light
pulse [73]. During subjective night (between CT 12 and CT
17), double transgenic mice showed a signiﬁcantly larger
phase delay on water compared to Dox treatment (Figure 5B).
The difference between the two treatments (water versus
Dox) is more clearly demonstrated when the data are
presented as a PRC (Figure 5C). Therefore, brain/SCN-
speciﬁc activation of the Clock
D19-HA TG affects both the
phase resetting, as well as, the period lengthening effects on
locomotor activity rhythms, similar to that seen with the
original Clock
D19/þ heterozygous mutation in the whole
animal.
Conditional Regulation of the Clock
wt Allele
In our previous report on the rescue of the Clock mutation
using bacterial artiﬁcial chromosome (BAC) TGs, we showed
that overexpression of WT Clock allele (Clock
wt) shortened
free-running period length beyond the WT range [66]. Thus,
we explored whether a conditional expression of Clock
wt,
restricted to the SCN and brain, could also generate
shortened free-running activity rhythms as observed in
transgenic mice that overexpress CLOCK
wt ubiquitously.
We have crossed one of the tetO::Clock
wt-HA target lines to
the Scg2::tTA activator line, and progeny from the mating
were examined for their locomotor activity rhythm. We ﬁnd
that the Scg2::tTA/tetO::Clock
wt-HA double transgenic mice
exhibit a shortened circadian period by about 1 h compared
to the WT circadian period (Figure 6). In addition, similar to
transcriptional activation of the Clock
D19-HA TG, we demon-
strate temporal control of Clock
wt-HA TG expression with
rapid switch-off and a rapid reversal. Therefore, conditional
expression of the dominant-negative mutant allele, as well as
overexpression of the WT allele, restricted to the SCN and
brain, is sufﬁcient to alter the period of activity rhythms.
Given that the peripheral circadian oscillators in these mice
are WT, it will be interesting in future experiments to
investigate whether the period of peripheral oscillators in
these mice can be regulated as a consequence of period
changes induced by the SCN/brain as previously suggested in
experiments using transplanted mouse embryonic ﬁbroblasts
[20].
Discussion
Signiﬁcant progress has been made in unraveling the
molecular mechanism underlying the mammalian circadian
system. The core molecular circuitry of opposing interlocking
transcriptional feedback loops has been deﬁned as the
fundamental basis of the circadian clock [2,74]; however,
Figure 4. Rapid Inhibition and Reversal of tTA Mediated tetO::Clock
D19-HA Transcription in Scg2::tTA/tetO::Clock
D19-HA Double Transgenic Mice to a
Lower Concentration of Dox
Representative actograms of (A) a single transgenic tetO::Clock
D19-HA mice and (B–D) double transgenic Scg2::tTA/tetO::Clock
D19-HA mice on 10 lg/ml
Dox treatment. Administration of 10 lg/ml Dox was just as effective as 2 mg/ml Dox on the free-running wheel period; all double transgenic mice
showed a shortening of circadian period. Withdrawal of Dox ( Dox, second arrow) led to reversal back to the previous long circadian period by next
day.
(E) Comparison of free-running period estimates for all four genotypes. Data are presented as mean with corresponding 95% confidence interval.
Numbers on the bottom of the bars indicate the number of animals in each group that were wheel tested for their locomotor activity rhythm. Overall,
there were significant differences in mean circadian period among genotypes (F3,78¼118.77, p , 0.00005). Pairwise comparisons indicated that there
were no significant differences on circadian period in single transgenic lines (Scg2::tTA or tetO::Clock
D19-HA) compared to the WT littermates; however, a
significantly longer free-running period was observed in double transgenic mice compared to WT, Scg2::tTA, and tetO::Clock
D19-HA (*p , 0.0005 for
each comparison), indicating that the transgenically induced Clock
D19-HA TG expression causes this period difference. With administration of 10 lg/ml
Dox, no difference was observed among the genotypes on circadian period (F3,62 ¼ 1.93, p ¼ 0.1339), thus the transgenically induced Clock
D19-HA TG
expression was ‘‘turned off.’’ Rapid reversal was achieved when the double transgenic mice were returned to water treatment ( Dox); their free-running
period reverted back to the previous circadian period, lengthening about 1 h (**paired t-test, t22 ¼  17.2177, p , 0.00005).
(F) In situ hybridization of the Clock
D19-HA transcript on coronal brain slices from the single tetO::Clock
D19-HA and double transgenic mice (Scg2::tTA/
tetO::Clock
D19-HA) on water ( Dox, left side) and 10 lg/ml Dox (þDox, right side) treatments, respectively. TG transcript was detected using an antisense
HA oligo probe. The transgenically induced ClockD19-HA transcript is ‘‘turned off’’ by day 3 on 10 lg/ml Dox treatment.
doi:10.1371/journal.pgen.0030033.g004
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Tet-Regulated Clock Gene Expression in BrainFigure 5. Light-Induced Phase Shifting Responses in Scg2::tTA/tetO::Clock
D19-HA Double Transgenic Mice
(A) Two examples of locomotor activity records of double transgenic mice, where they received a 6-h light pulse, during no treatment (water,
expression of Clock
D19-HA TG) and during Dox treatment (þDox, repression of Clock
D19-HA TG). All light pulse experiments were carried out after the
animals were released into DD. For mouse 230, a 6-h light pulse was given at CT 16 on water treatment and at CT 16.4 on Dox treatment. For mouse
234, a 6-h light pulse was given at the same CT of 16.7 on water and on Dox treatments. The red arrow indicates the time at which the mice were light
pulsed.
(B) Comparison of light-induced phase shifts in 20 individual double transgenic mice following a 6-h light pulse either during water or 10 lg/ml Dox
treatment. Data shown represent animals that received light pulses between CT 12 to CT 18. The symbol on the left side indicates phase delay of each
mouse after a light pulse on water treatment (Clock
D19-HA TG expression on). The symbol on the right side indicates phase delay of the same mouse on
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nents of the circuitry [75–78], the complexity and network
intricacy of the clock system are becoming apparent
[2,11,50,79]. Ultimately, we want to understand how these
cell-autonomous circadian oscillators interact in multicellu-
lar organisms to regulate physiology and behavior [80]. Thus,
to elucidate the mechanisms governing the hierarchical
nature of mammalian circadian timing, it is necessary to
develop genetic tools to manipulate circadian genes in a
conditional and tissue-speciﬁc manner in vivo.
We adapted an in vivo transgenic method, the tTA system,
to regulate Clock gene expression in a conditional and
reversible manner. This is a signiﬁcant technical milestone
that has not been previously demonstrated in the mammalian
circadian system. In this report, we generated an SCN- and
brain-enriched tTA-expressing transgenic line, which can
transactivate any transcript of choice when crossed to tetO-
responsive transgenic lines. We also produced target lines
that can express a Clock
D19 mutant allele or Clock
wt allele in a
tissue-speciﬁc manner when crossed to a transactivator
transgenic line. The Clock
D19 allele is a dominant-negative
mutation (antimorph) [56] and is an ideal allele to validate the
tTA system for circadian experiments for several reasons.
First, the Clock gene, with its heterodimeric partner Bmal1/
Mop3, is one of the primary transcriptional activators of the
circadian transcriptional autoregulatory feedback loop.
Second, the Clock
D19 mutation in mice perturbs the circadian
system and causes a signiﬁcantly altered running-wheel
rhythm that is clearly distinguishable from WT [56,57,65,66].
The antimorphic nature of this mutation, which has a
phenotypic effect that is antagonistic with the normal allele,
allows manifestation of the mutant phenotype in the
presence of the WT allele. Third, we have previously
demonstrated not only that transgenic expression of WT
Dox treatment (Clock
D19-HA TG expression off). Animals were light pulsed at a given CT during water treatment and then the animals were later treated
with Dox to turn off the TG. Animals were light pulsed again at the closest CT as possible to the original light pulse, within 1-h window (blue lines) or
within 1- to 2-h window (purple lines). All double transgenic mice show a larger phase shift after a light pulse with water treatment, when the TG is on,
compared to with Dox treatment, when the TG is turned-off (for 0- to 1-h CT interval, paired t-test, t8 ¼ 6.6026, p ¼ 0.0002; for 1- to 2-h CT interval,
paired t-test, t10 ¼ 11.5582, p , 0.00005).
(C) PRC to discrete pulses of light in Scg2::tTA/tetO::Clock
D19-HA double transgenic mice. The x-axis indicates the CT at the beginning of the light pulse.
The y-axis indicates the phase shift (in hours) produced by the light pulse. When the Clock
D19-HA TG is on, the double transgenic mice showed a
characteristic increased amplitude PRC, similar to the behavior seen in heterozygous Clock
D19 mutant mice after discrete pulses of light; however, when
the TG is off, the PRC in double transgenic mice is similar to behavior observed in WT mice.
doi:10.1371/journal.pgen.0030033.g005
Figure 6. Locomotor Activity Records of Progeny from Scg2::tTA 3 tetO::Clock
wt -HA Matings: Representative Actograms
Actograms of (A) WT, (B) single transgenic Scg2-tTA, (C) single transgenic tetO::Clock
wt-HA, and (D and E) double transgenic Scg2::tTA/tetO::Clock
wt-HA
mice. All double transgenic mice, expressing the Clock
wt -HA TG, showed a shortening of circadian period of approximately 1 h, beyond the normal WT
values. Mice that carry only a single TG (Scg2::tTA or tetO::Clock
D19-HA) showed circadian period range similar to their WT littermates. At the first arrow,
all animals were given Dox (10 lg/ml) to turn off transgenically induced CLOCK
wt-HA. At the second arrow, Dox was withdrawn to switch back on the
Clock
wt-HA TG. A similar effect on circadian period was observed when Dox was administered and withdrawn for the second time in the same animal.
doi:10.1371/journal.pgen.0030033.g006
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in Clock mutant mice but also that overexpression of the
Clock
wt TG ubiquitously results in period shortening beyond
the normal WT values [66]. Fourth, Clock gene expression in
the SCN is constitutive, which is easier to mimic with tTA
system. Finally, all circadian clock mutants that have been
analyzed in mammals thus far have been germline mutations
(either ENU-induced or gene targeted), and therefore the
developmental consequences of these mutations have not
been addressed. For all of these reasons, we set out to test
conditional expression of Clock on circadian behavior.
Interestingly, the circadian periodicity of Scg2::tTA/
tetO::Clock
D19-HA double transgenic mice provides a real-
time readout of the transactivation state of this system. This
allowed us to follow the kinetics of Dox regulation on a day-
to-day basis and revealed that high doses of Dox (2 mg/ml)
required many months of time to washout and reverse. This
then gave us the opportunity to ﬁnd optimal Dox dose
treatments for both inactivation and reversal of tet-depend-
ent transactivation in the brain of mice. SCN-directed
expression of the dominant-negative Clock
D19 TG lengthens
the circadian free-running period, whereas expression of the
Clock
wt TG shortens the circadian rhythm. Furthermore, we
showed that temporal and spatial control of TG expression
can revert the phenotype from a mutant to a WT state within
individuals, and vice versa, with a low concentration of Dox
treatment, so that experiments can be performed in a
longitudinal fashion. This is akin to transplant experiments
[17–19] with the added ability to reverse the procedure.
Moreover, unlike transplant experiments, which only allow
for the receiving of intact humoral signals, our system also
retains intact synaptic connections of the SCN. Finally, the
expression of the TG affects not only the free-running
activity rhythm but also other expected circadian behavioral
responses, such as phase shifts to discrete light pulses. Thus,
the transgenic mice described in this report are a valuable
tool and will facilitate investigation of the functional
relationship between central and peripheral clocks.
The validation of the tTA system for conditional TG
expression in a variety of cell types and tissues has made it the
tool of choice for mammalian system research. Arguably,
some of the most signiﬁcant contributions were made by
several groups utilizing the Tet-system in vivo to study the
effects of conditional TG activation and repression on
various neurobiological process [35–39,43,45,81,82]. However,
our study differs uniquely from previous Tet system
applications in several ways. First, this is the ﬁrst report on
the mammalian circadian system where an SCN/brain-driver
is used to conditionally regulate clock genes in vivo. Only a
handful of studies reported have used the Tet system in the
brain and, thus, the availability of brain-speciﬁc drivers is
very limited. Furthermore, no drivers have previously been
shown to function in the SCN. Second, our study demon-
strates that circadian locomotor activity records give us a
unique opportunity to have a daily readout of the trans-
activation state in a noninvasive manner. We suspect that this
is likely due to a combination of the shorter half-life of the
target protein, CLOCK, and our optimization of the Dox
dosage used. Thus, we show that CLOCK is an excellent
indicator for the kinetics of Dox-dependent induction/
suppression in the brain. Third, we show that the standard
dose often used in Tet regulation studies (e.g., 2 mg/ml) is
excessively high. This leads to very slow kinetics of washout
and slow (weeks to months) reactivation of the TG after
standard doses of Dox treatment [49]. To date, only one study
has examined a time course of TG expression in the brain
tissues using luciferase activity as an indicator of the TG
expression and has suggested administering a 100-fold lower
dose (50 lg/ml) [36]. In our study, we demonstrate that even a
200-fold lower dose of 10 lg/ml in drinking water is sufﬁcient
to cross the blood-brain barrier and is equally effective in
turning off the TG, and subsequently regulate behavioral
state. With a lower dose, our results reveal that the washout is
rapid and, thus, multiple induction and suppression cycles of
the TG can be achieved within subjects with minimal time loss
and cost. Furthermore, the effectiveness of the low Dox
dosage is not driver speciﬁc. We have found that another
SCN- and brain-enriched driver to be inducible and
reversible using the same low dose administration (unpub-
lished data). Finally, this study provides an important set of
transgenic mouse resources for the circadian research
community.
Exploitation of these transgenic lines along with existing
genetic allelic series of circadian genes may yield fundamen-
tal insights into the mechanism by which circadian pace-
maker systems transmit information to control physiology
and behavior. In addition, by using peripheral tissue-speciﬁc
drivers, manipulations using the tTA system can yield a
wealth of knowledge on physiological processes tied to the
circadian machinery such as cell division, heme biosynthesis,
tumor suppression, metabolism, and bone remodeling [83–
87]. For example, we recently reported a dissection of tissue-
speciﬁc functions of the mammalian clock protein BMAL1
using the SCN- and brain-enriched driver line, which we
describe here, and a muscle-speciﬁc driver line. We showed
that distinct tissue-speciﬁc phenotype in Bmal1-null mice can
be rescued using the tTA system [88]. Moreover, tetracycline-
dependent genetic tools can also assist in elucidating
unexpected subtle phenotypes found in knockout mice of
some essential clock genes, such as Rev-erba and Clock [89,90],
and address our current criteria for deﬁnition of primary
clock components [3]. Besides being potentially useful for
such studies, the tTA system may be a great resource for the
discovery and in vivo validation of novel candidate genes that
may be involved in the central SCN oscillator and the output
pathway. The successful manipulation of conditional TG
expression in the SCN and brain in these studies will lay the
groundwork for the development and adaptation of other
tools such as the Cre/Lox system for tissue-speciﬁc knockout
and conditional inactivation of circadian genes. Furthermore,
by developing additional SCN subregional-speciﬁc drivers, we
can begin to decipher the function of the cellular hetero-
geneity of the mammalian SCN and to understand how these
pacemaking neurons are organized to mediate synchrony
within the SCN and the whole animal. The ﬂexibility of the
tTA system provides a means to dissect the cellular and
behavioral networks in the mammalian circadian system.
Materials and Methods
TG constructs. For the generation of tTA-expressing mice (trans-
activator line), a 1,153-bp fragment upstream of the translation start
site of the mouse Secretogranin II gene was ampliﬁed by PCR primers
59-AGTGATTCCTCTTACTAATCCATCTGTGAGAT-39 (forward)
and 59-GTCTTAAAGATTTCCTGAAAACATAGA-39 (reverse) using
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Institute Mouse BAC Library; Invitrogen, http://www.invitrogen.com).
The PCR product was ﬁrst cloned into the EcoRV restriction site in
pBluescript II SK( ) (pBlue) (Stratagene, http://www.stratagene.com).
This plasmid was then cut with EcoRI and was used to ligate a 9-kb
EcoRI promoter fragment isolated from the BAC clone RP23-470F8,
resulting in an intact 9,851-bp promoter fragment upstream of the
translation start site. This plasmid was named pBlue-Scg2promoter. A
1,453-bp EcoRI-XmnI fragment coding tTA was released from the
PMY20 plasmid (kindly provided by Mark Mayford [35]) and ligated
into the SalI restriction site of the pBlue-Scg2promoter plasmid, after
T4 DNA polymerase treatment of both fragments. This plasmid was
named Scg2::tTA and was linearized with NotI restriction enzyme
prior to microinjection. The linearized fragment was isolated using
the QIA Quick Gel Extraction Kit (Qiagen, http://www.qiagen.com)
and dialyzed for 4 h in 10 mM Tris-HCl (pH 7.5)/0.1 mM EDTA (pH
8.5) buffer before pronuclear injection.
For the generation of tetO target lines, we ﬁrst generated the 39-
HA–tagged WT Clock and mutant Clock
D19 cDNAs from the plasmids
pBlue-ClockWT and pBlue-ClockD19, respectively, as described
previously [57]. Each full-length cDNA also contained 388 bp of 59
untranslated region of Clock, which was generated from exons 1b, 2,
and 3. The following primers were used against the pBlue-ClockWT
or pBlue-ClockD19 plasmid to generate cDNAs by PCR using Pfu
DNA polymerase (Stratagene): 59-ATAAGAATGCGGCCGCGGG-
GAGGAGCGCGGCGGTAGCGGTG-39 (forward) and 59-
CCCAAGCTTCTAAAGAGCGTAATCTGGAACATCGTATGGG-
TACTGTGGCTGGACCTTGGAAGGGTCA-39 (reverse). Ampliﬁed
product was digested with NotI and HindIII, gel puriﬁed, and ligated
into the NotI-HindIII cloning site of the pTRE2 plasmid (Clontech,
http://www.clontech.com). These tetO::Clock
wt-HA and tetO::Clock
D19-
HA pTRE2 plasmids were linearized using DrdI/XmnI restriction
enzymes to exclude most of the vector backbone sequence prior to
pronuclear injection. All plasmids were sequence veriﬁed using the
ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction Kit
and analyzed on an ABI377 automated sequencer (Applied Bio-
systems, http://www.appliedbiosystems.com).
Transgenic animals. Transgenic mouse lines were generated by
pronuclear injection using standard techniques [91] and essentially as
described in Antoch et al. [66]. Brieﬂy, the linearized DNA fragment
was injected into fertilized mouse oocytes isolated from crosses of WT
CD1 matings at a concentration of 1 ng/ll. Transgenic mice were
identiﬁed by PCR analysis of genomic DNA prepared from tail biopsy
samples. PCR ampliﬁcation of the transactivator TG (Scg2::tTA) was
carried out using primers (forward primer 59-AGACAAGCTTGATG-
CAAATGAG-39; reverse primer 59-CAAGTGTATGGCCAGATCT-
CAA-39) that generate a 482-bp fragment. Two Scg2::tTA founder
lines were obtained and characterized, and one line was chosen for
the experiments presented here. For the tetO::Clock
wt-HA and
tetO::Clock
D19-HA TGs, genotyping was performed using 59-ATATG-
CAAGGCCAGGTTGTC-39 (forward primer) and 59-TCTGTGGCA-
TACTGGATGGA-39 (reverse primer), which generates a 258-bp
fragment. We produced eight tetO::ClockD19-HA lines and 13
tetO::Clock
wt-HA target lines. Each founder animal was maintained
as a congenic line by backcrossing to the C57BL/6J inbred strain for at
least four generations. All animals were raised in a 12/12-h light–dark
cycle from birth. All animal studies were conducted in accordance
with the regulation of the Committee on Animal Care and Use at
Northwestern University.
Dox treatment. Doxycycline hydrochloride (Sigma-Aldrich, http://
www.sigmaaldrich.com) was supplied in the drinking water at a
concentration of 2 mg/ml or 10 lg/ml. The Dox-containing water was
renewed every 2 to 3 d. Mice were supplied with regular food and
water with or without Dox ad libitum.
Circadian behavioral analysis. Wheel-running activity of singly
housed animals was recorded and analyzed essentially as described
[65]. Mice were entrained to a 12/12-h light–dark cycle for a minimum
of 7 d before they were released into constant darkness. Activity data
were collected as number of events per minute and recorded
continuously by a PC system (Chronobiology Kit; Stanford Software
Systems, http://www.query.com); data were analyzed using ClockLab
software (Actimetrics, Wilmette, Illinois, United States). The free-
running period was calculated (days 1 to 20 in DD) by using a v
2
periodogram [92]. For the light pulse experiments, a 6-h light pulse
(approximately 100 lux) was provided at a given CT, where CT 0
denotes the beginning of the subjective day and CT 12 denotes the
beginning of the subjective night. The magnitude of phase shift was
determined by measuring the phase difference, based on the activity
onset as a phase reference point, between regression lines ﬁt
immediately before the light pulse and at least seven consecutive
activity-onset times after the light pulse (excluding the four cycles
immediately after the pulse) as described previously [73]. The
magnitude of phase shift was corrected for circadian period as
estimated before the light pulse for each individual. All other
statistical analyses were performed using the Stata Statistical/Data
Analysis software (version Stata/SE 9.0; StataCorp, http://www.
statacorp.com).
Western blotting. Tissues were homogenized in a buffer containing
150 mM NaCl, 50 mM Tris (pH 7.4), 1% Triton X-100, 0.1% SDS, and
protease inhibitor cocktail (Complete; Roche Applied Science, http://
www.roche.com). Homogenates were cleared by centrifugation at
10,000gfor10minat48C,andsupernatantswerecollectedandprotein
concentration was estimated using Bio-Rad DC Protein Assay (Bio-
Rad, http://www.bio-rad.com) according to the manufacturer’s in-
structions. Total protein (40 lg) was mixed with sample buffer
according to the protocol of [93] and resolved on an 8% SDS–
polyacrylamide gel by electrophoresis. Thereafter, proteins were
electrotransferred onto a Poly Screen PVDF transfer membrane
(Perkin Elmer Life Sciences, http://www.perkinelmer.com). The mem-
braneswereblockedwithPBST(PBSþ0.1%Tween-20)containing5%
powder milk for 1 h and then incubated with the 3F10 mouse
monoclonal anti-HA–peroxidase antibody (1:500; Roche Applied
Science) or anti–actin-peroxidase antibody (1:1,000; Santa Cruz
Biotechnology, http://scbt.com) according to the manufacturer’s
protocol. Anti-CLOCK guinea pig antibody (1:1,000) was followed by
anti–guinea pig IgG secondary antisera horseradish peroxidase
(1:1,000; Jackson ImmunoResearch Laboratories, http://www.
jacksonimmuno.com). CLOCK guinea pig antibody was generously
provided by Choogon Lee (University of Florida, Tallahassee, Florida,
United States). Proteins were visualized with a chemiluminescence
detection system (ECL Western blotting detection analysis system;
Amersham Pharmacia, http://www.amersham.com) and with subse-
quent exposure to autoradiographic ﬁlm.
In situ hybridization. In situ hybridization procedures were
performed as described [94]. Brieﬂy, animals were sacriﬁced by
cervical dislocation; the brains were removed immediately, frozen on
dry ice, and stored at  80 8C. Sectioning, ﬁxation, hybridization, and
washing were performed as described. Sections were hybridized using
an antisense-HA oligo probe (59- AAGAGCGTAATCTGGAACATCG-
TATGGGTACTGTGGCTGG-39), a WT Clock oligo probe (59-
GCTCTAGCTGGTCTTTTAGATGCTGCATGGCTCCTAACT-
GAGCTG-39), or an Scg2 oligo probe (59-TTCAGCAGCTC-
CAGGGCGGAGTTGATCACCTTGGACTTGTCCAGGCGGGACAT-
39). Primers were 59-end-labeled with [c-
33P]ATP by using recombi-
nant terminal deoxynucleotidyl transferase (Invitrogen).
Immunocytochemistry. Animals were anesthetized with ketamine/
xylazine/saline cocktail (10 mg/ml ketamine, 2 mg/ml xylazine;
Phoenix Scientiﬁc, http://www.psiqv.com) at 0.01 ml/g body weight
and then perfused intracardially with 50 ml of 0.9% saline solution
followed by 50 ml of 4% paraformaldehyde (Sigma Aldrich) in 0.1 M
phosphate buffer (pH 7.2). The brains were removed and postﬁxed
for 24 to 48 h at 4 8C in 4% paraformaldehyde in 0.1 M phosphate
buffer. For immunocytochemistry, 50-lm coronal sections were
collected through the entire SCN using a VibroSlice microtome
(World Precision Instruments, http://www.wpiinc.com) and processed
free ﬂoating. Sections were incubated with mouse anti-HA.11 biotin-
labeled monoclonal antibody (BIOT-101L-100, 1:200; Covance Re-
search Products, http://www.crpinc.com) followed by anti-biotin,
mouse IgG1, monoclonal 2F5 conjugated with Alexa Fluor 488
secondary antibody (1:1,000; Invitrogen). A primary antibody to
either VIP (1:5,000; ImmunoStar Inc, http://www.immunostar.com) or
AVP (1:10,000 ImmunoStar Inc) was followed by Alexa Fluor 568 goat
anti-rabbit IgG (HþL) secondary antibody (1:1,000; Invitrogen). The
Alexa Fluor 488 signal was assigned a green pseudo-color, while the
Alexa Fluor 568 signal was assigned a red pseudo-color. Sections were
viewed with a Leica DMRXE7 confocal microscope with Ar (488 nm)
and green HeNe (543 nm) lasers in the Biological Imaging Facility at
Northwestern University (Evanston, Illinois, United States). Images
were captured by sequential excitation with each laser to avoid
crosstalk between the two wavelengths using the Leica Confocal
Software (version 2.61 build 1537).
b-Galactosidase staining. Mice carrying a tetO promoter-lacZ
reporter construct (lines lac1 and lac2) were generously provided
by Mark Mayford. All procedures were performed as described by
Low-Zeddies and Takahashi [80]. Brieﬂy, mice were anesthetized with
ketamine/xylazine/saline cocktail and then transcardially perfused
with chilled 0.1% heparin PBS. Brains were removed and postﬁxed
for 30 min in 4% paraformaldehyde PBS on ice and then stored
overnight in 20% sucrose PBS at 4 8C. Brains were frozen on dry ice,
embedded in Shandon Lipshaw M1 embedding matrix (Pittsburgh,
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thickness. Free-ﬂoating sections were collected in a wash buffer
(PBS with 2 mM MgCl2, 0.02% NP-40 [Sigma] [pH 7.3]) and then
incubated for 24 h at 37 8C in an X-gal staining solution (1 mg/ml 5-
bromo-4-chloro-3-indolyl-b-D-galactoside; Gold Biochemical, Long
Beach, New York, United States) dissolved in dimethyl sulfoxide
buffer containing 5 mM K3Fe(CN)6 and 5 mM K4Fe(CN)6). Finally,
sections were rinsed three times in the wash buffer and then mounted
in aqueous mounting medium (3:1 glycerol/PBS) on gelatin-coated
glass slides. Stained sections were viewed and photographed under
bright-ﬁeld illumination.
Supporting Information
Figure S1. Western Blot Analysis of Scg2::tTA/tetO::Clock
D19-HA
Double Trasngenic Mice
(A) Western blot analysis of CLOCK in cerebellar lysates from
Scg2::tTA/tetO::Clock
D19-HA double transgenic mice of seven inde-
pendent lines. The red asterisk indicates the WT protein, while the
green asterisk denotes the HA-tagged CLOCK
D19.
(B) Western blot analysis of CLOCK in cerebellar lysates from single
transgenic tetO::Clock
D19-HA mice of seven independent lines. Only
one line (line 12) shows leakiness of the tetO promoter. The eighth
independent line (line 71) also expressed the TG with a tight
regulation (unpublished data).
Found at doi:10.1371/journal.pgen.0030033.sg001 (1.0 MB PDF).
Figure S2. Immunocytochemical Analysis of Scg2::tTA/tetO::Clock
D19-
HA Double Transgenic Mice
Serial coronal sections from the rostral-caudal extent of the SCN
were double labeled to detect transgenically induced CLOCK
D19-HA
(green) and endogenous AVP (red). Overlay of CLOCK
D19-HA and
AVP expression is shown in the right column. Figures were captured
at 320 magniﬁcation.
Found at doi:10.1371/journal.pgen.0030033.sg002 (1.8 MB PDF).
Figure S3. Immunocytochemical Analysis of Scg2::tTA/tetO::Clock
D19-
HA Double Trasngeneic Mice
Serial coronal sections from the rostral-caudal extent of the SCN
were double labeled to detect transgenically induced CLOCK
D19-HA
(green) and endogenous VIP (red). Overlay of CLOCK
D19-HA and VIP
expression is shown in the right column. Figures were captured at
320 magniﬁcation.
Found at doi:10.1371/journal.pgen.0030033.sg003 (2.6 MB PDF).
Figure S4. Tetracycline Works as Well as Doxycycline for Reversal of
tTA-Mediated tetO::Clock
D19-HA Transcription in Scg2::tTA/
tetO::Clock
D19-HA Double Transgenic Mice
Administration of 100 lg/ml tetracycline in the drinking water was
just as effective as 10 lg/ml Dox in perturbing the free wheel-running
period behavior; all double transgenic mice (Scg2::tTA/tetO::ClockD19-
HA) show shortening of circadian period. A dosage of 100 lg/ml
tetracycline was rapidly reversible after the withdrawal.
Found at doi:10.1371/journal.pgen.0030033.sg004 (1.9 MB PDF).
Accession numbers
Accession numbers for genes used in this paper are mouse BAC clone
RP23-470F8 (GenBank [http://www.ncbi.nlm.nih.gov/Genbank]
AC084213), Clock (GenBank AF000998 [mRNA], AF146793 [genomic],
Entrez Gene ID 12753, UniProt O08785), Bmal1 (Arntl) (Entrez Gene
ID 11865, UniProt Q9WTL8), Scg2 (Entrez Gene ID 20254), Avp
(Entrez Gene ID 11998, UniProt P35455), and Vip (Entrez Gene ID
22353, UniProt P32648).
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